Utilizing inducible fibroblast-specific deletion of Txndc5 further confirms the pathogenic requirement of fibroblastic TXNDC5 in the development and progression of lung fibrosis, thereby preventing and even reversing pulmonary dysfunction in BLM-treated animals. This evidence concerns the gene TXNDC5 and pulmonary fibrosis.